Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:06:45 EST Fri 16 Jan 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for U:DTCFF from 2025-01-17 to 2026-01-16 - 23 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-12-11 08:35U:DTCFFNews ReleaseDefence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th
2025-12-10 16:31U:DTCFFNews ReleaseDefence Therapeutics Announces AGM Results and Provides Corporate Updates
2025-12-04 03:17U:DTCFFNews ReleaseDefence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
2025-11-21 18:04U:DTCFFNews ReleaseDefence Therapeutics Announces Convertible Debenture Conversion
2025-11-19 03:16U:DTCFFNews ReleaseDefence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology
2025-11-06 03:17U:DTCFFNews ReleaseDefence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs
2025-11-04 03:16U:DTCFFNews ReleaseDefence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
2025-10-23 03:16U:DTCFFNews ReleaseDefence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
2025-10-06 03:16U:DTCFFNews ReleaseDefence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
2025-10-02 03:16U:DTCFFNews ReleaseDefence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations
2025-09-23 09:16U:DTCFFNews ReleaseDefence's Director, Strategy & Business Advisor Dr. Amie Phinney Discusses the Accum Platform on Money Talk Radio with Ellis Martin
2025-09-23 03:03U:DTCFFNews ReleaseEllis Martin Report: Dr. Amie Phinney of Defence Therapeutics Inc. (DTCFF) on the Accum(TM) Platform
2025-09-16 03:16U:DTCFFNews ReleaseDefence Therapeutics Appoints Dr. Amie Phinney as Director
2025-09-15 16:31U:DTCFFNews ReleaseDefence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
2025-09-02 03:16U:DTCFFNews ReleaseDefence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
2025-08-22 20:31U:DTCFFNews ReleaseDefence Therapeutics Announces Debenture Units Financing
2025-07-14 03:16U:DTCFFNews ReleaseDefence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer
2025-06-09 03:16U:DTCFFNews ReleaseDefence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology
2025-06-02 03:16U:DTCFFNews ReleaseDefence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub
2025-05-28 03:16U:DTCFFNews ReleaseDefence Therapeutics to Attend Bio International Convention in Boston, June 2025
2025-04-08 03:16U:DTCFFNews ReleaseDefence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies
2025-03-26 03:16U:DTCFFNews ReleaseDefence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence's Management Team as Chief Operating Officer
2025-01-31 18:01U:DTCFFNews ReleaseDefence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million